• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma news

The latest news from the pharmaceutical industry and suppliers. If you have a piece of news that you would like us to cover, please contact Victoria White on +44 (0)1959 563311 or email us.

 

Synjardy granted marketing authorisation in the EU for the treatment of adults with type 2 diabetes

Posted on: 28 May 2015

Synjardy has been granted marketing authorisation by the European Commission for the treatment of adults with type 2 diabetes (T2D) in the European Union...

J&J accepts binding offer from Cardinal Health for Cordis

Posted on: 28 May 2015

Johnson & Johnson has accepted the 1 March 2015 binding offer from Cardinal Health to acquire its Cordis business for an approximate value of $2 billion...

First patient dosed in the Phase 2 study of SER-109 in recurrent Clostridium difficile infection

Posted on: 28 May 2015

Seres Therapeutics has enrolled and dosed the first patient in its Phase 2 clinical study of SER-109 in recurrent CDI in adults...

ESMO highlights the opportunities and challenges to come from the EU Clinical Trials Regulation

Posted on: 28 May 2015

ESMO, in collaboration with EORTC, have expressed their views on the EU Clinical Trials Regulation in an official position paper...

Pfizer announces initial results of its rheumatoid arthritis NarRAtive patient survey

Posted on: 28 May 2015

Pfizer has announced initial results of its global NarRAtive survey of more than 3,600 adults with rheumatoid arthritis in 13 countries...

Top-line results announced for Phase 2 study of GS-4774 in patients with chronic hepatitis B

Posted on: 28 May 2015

Top line results have been announced from the GS-4774 Phase 2 study in patients with HBV on long term viral suppression with an oral antiviral treatment...

Starting antiretroviral treatment early improves outcomes for HIV-infected individuals

Posted on: 28 May 2015

A trial has found that HIV-infected individuals have a lower risk of developing AIDS or other serious illnesses if given antiretroviral drugs sooner...

TA Instruments acquires assets of Bose Electroforce Group

Posted on: 28 May 2015

TA Instruments announced the acquisition of certain assets related to the Bose ElectroForce Group, from the Bose Corporation of Framingham Massachusetts...

FDA approves Stiolto Respimat Inhalation Spray as once-daily maintenance treatment of COPD

Posted on: 28 May 2015

The US Food and Drug Administration has approved Boehringer Ingelheim’s once-daily Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray...

Pharmaceutical sector celebrates as three companies named winners in European Business Awards

Posted on: 28 May 2015

The pharmaceuticals sector is celebrating a triple win following the 2014/15 European Business Awards exclusive awards ceremony in London...

STELARA receives CHMP positive opinion for treatment of adolescents with moderate to severe psoriasis

Posted on: 27 May 2015

The CHMP has recommended approval of STELARA for the treatment of moderate to severe plaque psoriasis in adolescent patients aged 12 and older...

Treatment with Saxenda for three years reduced the risk of developing type 2 diabetes

Posted on: 27 May 2015

The SCALE Obesity and Prediabetes trial met its primary endpoint, demonstrating that ongoing treatment with Saxenda delayed the onset of type 2 diabetes...